an improved hydrocephalus shunt
CSF-Dynamics is developing a new type of hydrocephalus shunt that overcomes the major issues of current shunts on the market. The shunt is currently undergoing clinical testing. CSF-Dynamics expects the shunt to be approved for clinical use by end 2027.
CSF-Dynamics received a Horizon 2020 Phase 2 SME grant (849502) from the European Commission to support our First in Human trial. We are now planning a larger Pivotal Study in 5 countries.
Please contact us by email if you are interested to know more about the technology and the status of the development.
After several years of research and technological development at CSF-Dynamics we can now present the results of the pilot study on our novel CSF-shunting device. This method of shunting to the intracranial sinus for the treatment of hydrocephalus is intended to significantly reduce both revisions and complications by mimicking physiological drainage. We would like to thank Dr Sune Munthe and his team at Odense University Hospital for supporting us in this First in Human investigation and showing that our outlet remains patent and avoids overdrainage. We are convinced that this method has a future in the standard of care and will move forwards to plan a larger study as soon as possible.
The abstract can be found on the Journal of Neurosurgery.